An M R, Hsieh C C, Reisner P D, Rabek J P, Scott S G, Kuninger D T, Papaconstantinou J
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, 77555, USA.
Mol Cell Biol. 1996 May;16(5):2295-306. doi: 10.1128/MCB.16.5.2295.
The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPalpha and C/EBPbeta) serve as templates for the differential translation of several isoforms which have specific transcriptional regulatory functions. By using an oligonucleotide corresponding to the C/EBP binding site of the mouse alpha1-acid glycoprotein promoter, we detected multiple forms of C/EBPalpha and C/EBP++ beta proteins in the mouse liver that have DNA-binding activity. By using specific antisera, we detected C/EBPalphas with molecular masses of 42, 38, 30, and 20 kDa that have DNA-binding activity. The pool levels of the 42- and 30-kDa isoforms were high in control nuclear extracts and decreased significantly after lipopolysaccharide (LPS) treatment. The binding activity and protein levels of the 20-kDa isoform are low in controls and increase dramatically after LPS treatment. C/EBPbeta isoforms with molecular masses of 35, 20, and 16 kDa were also detected. The 35-kDa pool level did not change whereas the 20-kDa isoform was strongly induced in response to LPS. Western (immunoblot) and Southwestern (DNA-protein) analyses show that p42 C/EBPalpha forms specific complexes with the alpha1-acid glycoprotein oligonucleotide in control nuclear extract and that p20 C/EBP beta forms complexes in LPS-treated liver. Our studies suggest that synthesis of specific C/EBPalpha and C/EBPbeta isoforms occurred in the normal liver in vivo and that LPS mediated a differential initiation and inhibition of translation at specific AUG sites within each mRNA. The qualitative and quantitative changes in C/EBPalpha and C/EBPbeta isoform pool levels suggest that LPS or an LPS-stimulated factor can regulate the selection of AUG start sites for both activation and repression of translation. This regulation appears to involve an LPS-mediated down-regulation of initiation at the first AUG codon of the 42-kDa C/EBPalpha and dramatic translational up-regulation at the fifth AUG codon of the 20-kDa C/EBPalpha and the third AUG codon of the 20-kDa C/EBPbeta. These regulatory events suggest the existence of proteins that may act as translational trans-acting factors.
CCAAT/增强子结合反式激活蛋白(C/EBPα和C/EBPβ)的mRNA作为几种具有特定转录调控功能的同工型差异翻译的模板。通过使用与小鼠α1-酸性糖蛋白启动子的C/EBP结合位点对应的寡核苷酸,我们在小鼠肝脏中检测到具有DNA结合活性的多种形式的C/EBPα和C/EBPβ蛋白。通过使用特异性抗血清,我们检测到分子量分别为42、38、30和20 kDa且具有DNA结合活性的C/EBPα。在对照核提取物中,42 kDa和30 kDa同工型的总量水平较高,而在脂多糖(LPS)处理后显著降低。20 kDa同工型的结合活性和蛋白水平在对照中较低,而在LPS处理后显著增加。还检测到分子量为35、20和16 kDa的C/EBPβ同工型。35 kDa的总量水平没有变化,而20 kDa同工型在LPS刺激下强烈诱导产生。蛋白质免疫印迹(Western)和DNA-蛋白质印迹(Southwestern)分析表明,在对照核提取物中,p42 C/EBPα与α1-酸性糖蛋白寡核苷酸形成特异性复合物,而在LPS处理的肝脏中,p20 C/EBPβ形成复合物。我们的研究表明,在正常肝脏中体内发生了特异性C/EBPα和C/EBPβ同工型的合成,并且LPS介导了每个mRNA内特定AUG位点的差异起始和翻译抑制。C/EBPα和C/EBPβ同工型总量水平的定性和定量变化表明,LPS或LPS刺激因子可以调节AUG起始位点的选择,从而激活和抑制翻译。这种调节似乎涉及LPS介导的对42 kDa C/EBPα第一个AUG密码子起始的下调,以及对20 kDa C/EBPα第五个AUG密码子和20 kDa C/EBPβ第三个AUG密码子翻译的显著上调。这些调控事件表明存在可能作为翻译反式作用因子的蛋白质。